Related Experiment Video
Updated: Oct 5, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Effect of Cis-Compound Variants in MYH7 on Hypertrophic Cardiomyopathy With a Mild Phenotype
Mo Zhang1, Xiaolu Sun1, Guixin Wu2
1Department of Cardiology.
Insights
Compound variants in the MYH7 gene can cause hypertrophic cardiomyopathy (HC). This study found cis-compound variants (Met822Thr and Arg1420Trp) are causal but relatively benign in a Chinese family.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HC) patients with compound variants show severe manifestations but clinical heterogeneity.
- This diversity may stem from varying combinations of genetic variants.
- Understanding variant interactions is crucial for genotype-phenotype correlations in HC.
Purpose of the Study:
- To investigate the role of cis-compound variants in the MYH7 gene within a Chinese hypertrophic cardiomyopathy pedigree.
- To analyze the genotype-phenotype relationship associated with specific cis-compound variants in MYH7.
Main Methods:
- Exome sequencing was performed on the proband.
- Bi-directional Sanger sequencing was used to analyze variants in a 3-generation, 28-member pedigree.
- A 16-year follow-up was conducted on affected family members.
Main Results:
- Two pathogenic missense variants (c.2465T>C, p.Met822Thr; c.4258C>T, p.Arg1420Trp) in the MYH7 gene were identified.
- These cis-compound variants were present in 11 family members; 5 developed HC, while 6 remained asymptomatic carriers with abnormal ECGs.
- HC patients exhibited mild hypertrophy (13-21 mm wall thickness) and a low incidence of cardiovascular events.
Conclusions:
- Cis-compound variants Met822Thr and Arg1420Trp in MYH7 are causal for familial HC but associated with relatively benign clinical outcomes.
- Different types of compound variants may require distinct analyses for accurate genotype-phenotype studies in HC.
- This study highlights the importance of considering variant combinations in understanding HC heterogeneity.
Abstract:
Patients with hypertrophic cardiomyopathy (HC) caused by compound variants have severe clinical manifestations, but significant clinical heterogeneity remains. Clinical diversity in these patients may result from different combinations of variants. We analyzed the role of cis-compound variants in a Chinese HC pedigree. Exome sequencing was performed in the proband. Identified variants were detected with bi-directional Sanger sequencing in a pedigree that comprised 3 generations and 28 family members. Follow-up was performed for 16 years. Two missense variants (c.2465T>C, p.Met822Thr; c.4258C>T, p.Arg1420Trp) were identified in the MYH7 gene. These variants were absent in our 761 in-house people without HC and predicted to be pathogenic.Both variants were detected in 11 family members, thus they were believed to inherit cis. In the 11 members, only 5 developed HC, the other 6 were asymptomatic variant carriers with an abnormal electrocardiogram. The HC members had mild hypertrophy with a maximum left ventricular wall thickness of 13 to 21 mm and showed a low incidence of cardiovascular events. In conclusion, the cis-compound variants of Met822Thr and Arg1420Trp in MYH7 are causal but relatively benign, variants associated with familial HC. This finding suggests that different types of compound variants might need to be analyzed for a genotype-phenotype study.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction

